Literature DB >> 16930758

Severe insulin resistance associated with subcutaneous amyloid deposition.

Stewart G Albert, Joseph Obadiah, Shant A Parseghian, M Yadira Hurley, Arshag D Mooradian.   

Abstract

A 59-year-old man with type 1 diabetes mellitus presented with severe resistance to subcutaneously injected insulin. Histological analysis of the injection sites, demonstrated foreign body type granulomas surrounding areas of amyloidosis. It is suggested that the granulomas were the source of an insulin-degrading enzyme (IDE) which simultaneously degraded amyloidogenic precursors into localized amyloid deposits. These findings may add insight into the role of insulin-degrading enzymes in the etiology of subcutaneous insulin resistance syndromes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930758     DOI: 10.1016/j.diabres.2006.07.013

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  11 in total

1.  Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis.

Authors:  Carlo O Martins; Cecilia Lezcano; San S Yi; Heather J Landau; Jessica R Chapman; Ahmet Dogan
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

2.  Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration.

Authors:  Anita D'Souza; Jason D Theis; Julie A Vrana; Ahmet Dogan
Journal:  Amyloid       Date:  2014-01-22       Impact factor: 7.141

3.  Imaging characteristics of subcutaneous amyloid deposits in diabetic patients: the "insulin ball".

Authors:  Noriko Tanio; Taiki Nozaki; Masaki Matsusako; Jay Starkey; Koyu Suzuki
Journal:  Skeletal Radiol       Date:  2017-08-28       Impact factor: 2.199

4.  Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.

Authors:  Julie A Vrana; Jason D Theis; Surendra Dasari; Oana M Mereuta; Angela Dispenzieri; Steven R Zeldenrust; Morie A Gertz; Paul J Kurtin; Karen L Grogg; Ahmet Dogan
Journal:  Haematologica       Date:  2014-04-18       Impact factor: 9.941

5.  The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model.

Authors:  Mahvish Muzaffar; Atta Ahmad
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

6.  Insulin-derived amyloidosis.

Authors:  Yashdeep Gupta; Gaurav Singla; Rajiv Singla
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

Review 7.  Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015.

Authors:  Nikhil Tandon; Sanjay Kalra; Yatan Pal Singh Balhara; Manash P Baruah; Manoj Chadha; Hemraj B Chandalia; Subhankar Chowdhury; Kesavadev Jothydev; Prasanna K M Kumar; Madhu S V; Ambrish Mithal; Sonal Modi; Shailesh Pitale; Rakesh Sahay; Rishi Shukla; Annamalai Sundaram; Ambika G Unnikrishnan; Subhash K Wangnoo
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun

8.  A Small Molecule Impedes Insulin Fibrillation: Another New Role of Phenothiazine Derivatives.

Authors:  Meghomukta Mukherjee; Jagannath Jana; Subhrangsu Chatterjee
Journal:  ChemistryOpen       Date:  2017-12-07       Impact factor: 2.911

9.  Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.

Authors:  Shintaro Okamura; Yasuaki Hayashino; Satoshi Kore-Eda; Satoru Tsujii
Journal:  Diabetes Care       Date:  2013-12       Impact factor: 19.112

10.  Generating local amyloidosis in mice by the subcutaneous injection of human insulin amyloid fibrils.

Authors:  Maryam Chinisaz; Azadeh Ebrahim-Habibi; Parichehreh Yaghmaei; Kazem Parivar; Ahmad-Reza Dehpour
Journal:  Exp Ther Med       Date:  2014-06-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.